Discounted Cash Flow Rating
Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Sell
Price to Earnings Rating
Buy
Analyst Rating
Sell
Simple Moving Average
Buy
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Virax Biolabs Group Limited Ordinary Shares (VRAX)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
07/21/2022
Market Cap
4,463,760
Shares Outstanding
1,810,000
Weighted SO
1,811,539
Total Employees
N/A
Upcoming Earnings
N/A
Beta
1.5560
Last Div
0.0000
Range
0.6-4.0
Chg
0.4999
Avg Vol
1604591
Mkt Cap
4463760
Exch
NASDAQ
Country
GB
Phone
44 20 7788 7414
DCF Diff
0.2159
DCF
0.8051
Div Yield
0.0000
P/S
56.2888
EV Multiple
0.0662
P/FV
0.5298
Div Yield %
0.0000
P/E
-0.4846
PEG
0.0020
Payout
0.0000
Current Ratio
7.5870
Quick Ratio
7.5559
Cash Ratio
6.4901
DSO
843.9587
DIO
127.3079
Op Cycle
971.2666
DPO
2122.5800
CCC
-1151.3134
Gross Margin
0.1139
Op Margin
-88.2512
Pretax Margin
-87.2395
Net Margin
-87.3070
Eff Tax Rate
0.6196
ROA
-0.9855
ROE
-0.8957
ROCE
-1.1219
NI/EBT
1.0008
EBT/EBIT
0.9885
EBIT/Rev
-88.2512
Debt Ratio
0.0259
D/E
0.0287
LT Debt/Cap
0.0204
Total Debt/Cap
0.0279
Int Coverage
-438.1126
CF/Debt
-29.3933
Equity Multi
1.1093
Rec Turnover
0.4325
Pay Turnover
0.1720
Inv Turnover
2.8671
FA Turnover
0.1167
Asset Turnover
0.0113
OCF/Share
-3.0085
FCF/Share
-3.5079
Cash/Share
2.9322
OCF/Sales
-67.3501
FCF/OCF
1.1660
CF Coverage
-29.3933
ST Coverage
-107.5088
CapEx Coverage
-6.0242
Div&CapEx Cov
-6.0242
P/BV
0.5298
P/B
0.5298
P/S
56.2888
P/E
-0.4846
P/FCF
-0.7168
P/OCF
-0.6282
P/CF
-0.6282
PEG
0.0020
P/S
56.2888
EV Multiple
0.0662
P/FV
0.5298
DPS
0.0000